Covid-19 forced pharma and medtech companies to rethink their clinical trial operations. Companies were dealing with reduced lab capacity, and new patient enrollment (as well as retaining old ones), which was a serious challenge, and internal change management of processes was not easy. One of the ways in which the pharma and medical device industry has built resilience is by adopting digital tools with agility.
In this e-book on Digitization of Clinical Trials, we examine:
- How technology can benefit patient recruitment and engagement during clinical trials
- Prioritize communication through an integrated CTMS
- 4 exciting digital developments in the clinical trials industry
- Artificial Intelligence – will it become a critical prerequisite for streamlining processes during clinical trials?
Take a deep dive into the world of pharma and medical device companies embracing AI and data-driven digital tools to streamline the clinical trial management workflow.